1 Martin, G. M. The biology of aging: 1985-2010 and beyond. Faseb j25, 3756-3762, doi:10.1096/fj.11-1102.ufm (2011).
2 van den Beld, A. W. et al. The physiology of endocrine systems with ageing. Lancet Diabetes Endocrinol6, 647-658, doi:10.1016/s2213-8587(18)30026-3 (2018).
3 Broughton, D. L. & Taylor, R. Review: deterioration of glucose tolerance with age: the role of insulin resistance. Age Ageing20, 221-225, doi:10.1093/ageing/20.3.221 (1991).
4 Yang, W. et al. Prevalence of diabetes among men and women in China. N Engl J Med362, 1090-1101, doi:10.1056/NEJMoa0908292 (2010).
5 Fonseca, V. A. Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease. Am J Cardiol92, 50j-60j, doi:10.1016/s0002-9149(03)00616-7 (2003).
6 Xiao, J. et al. Worse pancreatic beta-cell function and better insulin sensitivity in older Chinese without diabetes. J Gerontol A Biol Sci Med Sci69, 463-470, doi:10.1093/gerona/glt104 (2014).
7 Karakelides, H., Irving, B. A., Short, K. R., O'Brien, P. & Nair, K. S. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes59, 89-97, doi:10.2337/db09-0591 (2010).
8 Jackson, R. A. et al. Influence of ageing on glucose homeostasis. J Clin Endocrinol Metab55, 840-848, doi:10.1210/jcem-55-5-840 (1982).
9 Michalakis, K. et al. Obesity in the ageing man. Metabolism62, 1341-1349, doi:10.1016/j.metabol.2013.05.019 (2013).
10 Atkins, J. L., Whincup, P. H., Morris, R. W. & Wannamethee, S. G. Low muscle mass in older men: the role of lifestyle, diet and cardiovascular risk factors. J Nutr Health Aging18, 26-33, doi:10.1007/s12603-013-0336-9 (2014).
11 Petersen, K. F. et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science300, 1140-1142, doi:10.1126/science.1082889 (2003).
12 Maggio, M. et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab292, E353-358, doi:10.1152/ajpendo.00339.2006 (2007).
13 Rains, J. L. & Jain, S. K. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med50, 567-575, doi:10.1016/j.freeradbiomed.2010.12.006 (2011).
14 Singh, T. & Newman, A. B. Inflammatory markers in population studies of aging. Ageing Res Rev10, 319-329, doi:10.1016/j.arr.2010.11.002 (2011).
15 Voipio-Pulkki, L. M. et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med34, 2064-2067 (1993).
16 Bingham, E. M. et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes51, 3384-3390, doi:10.2337/diabetes.51.12.3384 (2002).
17 Virtanen, K. A. et al. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis. Diabetologia44, 2171-2179, doi:10.1007/s001250100026 (2001).
18 Reaven, G. M. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition13, 65; discussion 64, 66 (1997).
19 Cefalu, W. T. et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism44, 954-959, doi:10.1016/0026-0495(95)90251-1 (1995).
20 Coon, P. J., Rogus, E. M., Drinkwater, D., Muller, D. C. & Goldberg, A. P. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab75, 1125-1132, doi:10.1210/jcem.75.4.1400882 (1992).
21 Lindström, J. & Tuomilehto, J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care26, 725-731, doi:10.2337/diacare.26.3.725 (2003).
22 Salmon, A. B. Oxidative stress in the etiology of age-associated decline in glucose metabolism. Longev Healthspan1, 7, doi:10.1186/2046-2395-1-7 (2012).
23 Chumlea, W. C., Rhyne, R. L., Garry, P. J. & Hunt, W. C. Changes in anthropometric indices of body composition with age in a healthy elderly population. Am J Hum Biol1, 457-462, doi:10.1002/ajhb.1310010408 (1989).
24 Barbieri, M., Rizzo, M. R., Manzella, D. & Paolisso, G. Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev17, 19-26, doi:10.1002/dmrr.178 (2001).
25 Fried, S. K., Leibel, R. L., Edens, N. K. & Kral, J. G. Lipolysis in intraabdominal adipose tissues of obese women and men. Obes Res1, 443-448, doi:10.1002/j.1550-8528.1993.tb00026.x (1993).
26 Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes46, 3-10 (1997).
27 Mauriège, P. et al. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men? J Clin Endocrinol Metab84, 736-742, doi:10.1210/jcem.84.2.5499 (1999).
28 MacLean, P. S., Zheng, D., Jones, J. P., Olson, A. L. & Dohm, G. L. Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochem Biophys Res Commun292, 409-414, doi:10.1006/bbrc.2002.6654 (2002).
29 Cheng, C. et al. Evaluation of organ-specific glucose metabolism by (1)(8)F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance. Ann Nucl Med25, 755-761, doi:10.1007/s12149-011-0522-y (2011).
30 James, D. E. Targeting of the insulin-regulatable glucose transporter (GLUT-4). Biochem Soc Trans22, 668-670, doi:10.1042/bst0220668 (1994).
31 De Tata, V. Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne)5, 138, doi:10.3389/fendo.2014.00138 (2014).
32 Zhao, S. et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med28, 730-735, doi:10.1007/s002590100517 (2001).
33 Torizuka, T., Fisher, S. J. & Wahl, R. L. Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma. Radiology203, 169-172, doi:10.1148/radiology.203.1.9122387 (1997).
34 Page, M. M. & Johnson, J. D. Mild Suppression of Hyperinsulinemia to Treat Obesity and Insulin Resistance. Trends Endocrinol Metab29, 389-399, doi:10.1016/j.tem.2018.03.018 (2018).
35 Shanik, M. H. et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care31 Suppl 2, S262-268, doi:10.2337/dc08-s264 (2008).
36 Mehran, A. E. et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab16, 723-737, doi:10.1016/j.cmet.2012.10.019 (2012).
37 De Cosmo, S., Menzaghi, C., Prudente, S. & Trischitta, V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant28, 29-36, doi:10.1093/ndt/gfs290 (2013).
38 de Boer, I. H. et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. Jama305, 2532-2539, doi:10.1001/jama.2011.861 (2011).
39 Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes37, 1595-1607, doi:10.2337/diab.37.12.1595 (1988).
40 Chen, J. et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med140, 167-174, doi:10.7326/0003-4819-140-3-200402030-00007 (2004).
41 Formoso, G. et al. The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. Cardiovasc Res89, 184-192, doi:10.1093/cvr/cvq255 (2011).
42 Prudente, S., Morini, E. & Trischitta, V. Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol5, 682-693, doi:10.1038/nrendo.2009.215 (2009).
43 Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. & Gispen, W. H. Ageing and diabetes: implications for brain function. Eur J Pharmacol441, 1-14, doi:10.1016/s0014-2999(02)01486-3 (2002).
44 Cholerton, B., Baker, L. D. & Craft, S. Insulin resistance and pathological brain ageing. Diabet Med28, 1463-1475, doi:10.1111/j.1464-5491.2011.03464.x (2011).
45 Frazier, H. N. et al. Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents. Neurochem Res44, 269-280, doi:10.1007/s11064-018-2510-2 (2019).
46 Rhea, E. M. & Banks, W. A. Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance. Front Neurosci13, 521, doi:10.3389/fnins.2019.00521 (2019).
47 Reagan, L. P. et al. Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci U S A98, 2820-2825, doi:10.1073/pnas.051629798 (2001).
48 Schulingkamp, R. J., Pagano, T. C., Hung, D. & Raffa, R. B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev24, 855-872, doi:10.1016/s0149-7634(00)00040-3 (2000).
49 Piroli, G. G. et al. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology85, 71-80, doi:10.1159/000101694 (2007).
50 Oriuchi, N. et al. Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using (211)At-CXCR4 monoclonal antibody. Sci Rep10, 6810, doi:10.1038/s41598-020-63557-9 (2020).
51 Zhao, S. et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med46, 675-682 (2005).